Cathepsin D in podocytes is important in the pathogenesis of proteinuria and CKD

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2685-2700

  Yamamoto Nonaka, Kanae ^a   Koike, Masato ^b   Asanuma, Katsuhiko ^a,c   Takagi, Miyuki ^a   Oliva Trejo, Juan Alejandro ^c   Seki, Takuto ^a   Hidaka, Teruo ^a   Ichimura, Koichiro ^b   Sakai, Tatsuo ^b   Tada, Norihiro ^d   Ueno, Takashi ^e   Uchiyama, Yasuo ^f   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Cell Biology and Neuroscience ^*  (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Research Institute for Disease of Old Age   (Japan)

^e Research Support Center   (Japan)

^f JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CATHEPSIN D; CREATININE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NEPHRIN; PODOCIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RAB7 PROTEIN; CTSD PROTEIN, MOUSE;

AGING; ALBUMINURIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CELL BODY; CELL DEATH; CELL STRUCTURE; CELLULAR DISTRIBUTION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIAPHRAGM; DISEASE COURSE; ELECTRON MICROSCOPY; END STAGE RENAL DISEASE; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HISTOLOGY; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNER MEMBRANE; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SCANNING ELECTRON MICROSCOPY; TISSUE SECTION; TUNEL ASSAY; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; CATHEPSIN D; MICE; MICE, KNOCKOUT; PODOCYTES; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84987861571     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015040366     Document Type: Article

References (51)

1. CurrieG,DellesC: Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis 7: 13-24, 2013
2. Smoyer WE, Mundel P: Regulation of podocyte structure during the development of nephrotic syndrome. J Mol Med (Berl) 76: 172-183, 1998
3. Wang W, Tzanidis A, DivjakM, ThomsonNM, Stein-Oakley AN: Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 12: 1422-1433, 2001
4. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005
5. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006
6. Uchiyama Y, Waguri S, Sato N,Watanabe T, Ishido K, Kominami E: Cell and tissue distribution of lysosomal cysteine proteinases, cathepsins B, H, and L, and their biological roles. Acta Histochem Cytochem 27: 287-308, 1994
7. Sever S, AltintasMM,Nankoe SR,MöllerCC, Ko D,WeiC,Henderson J, del Re EC, Hsing L, Erickson A, Cohen CD, Kretzler M, Kerjaschki D, Rudensky A, Nikolic B, Reiser J: Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 117: 2095-2104, 2007
8. Reiser J, Oh J, Shirato I, Asanuma K, Hug A, Mundel TM, Honey K, Ishidoh K, Kominami E, Kreidberg JA, Tomino Y, Mundel P: Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem 279: 34827-34832, 2004
9. Faul C, DonnellyM, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938, 2008
10. Yaddanapudi S,AltintasMM, KistlerAD, Fernandez I,MöllerCC,WeiC, Peev V, Flesche JB, Forst AL, Li J, Patrakka J, Xiao Z, Grahammer F, Schiffer M, Lohmüller T, Reinheckel T, Gu C, Huber TB, JuW, Bitzer M, Rastaldi MP, Ruiz P, Tryggvason K, Shaw AS, Faul C, Sever S, Reiser J: CD2AP inmouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest 121: 3965-3980, 2011
11. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 80: 535-561, 1981
12. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Köster A, Hess B, EversM, von Figura K, Peters C:Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBOJ 14: 3599-3608, 1995
13. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y, Schulz-Schaeffer W, Watanabe T, Waguri S, Kametaka S, Shibata M, Yamamoto K, Kominami E, Peters C, von Figura K, Uchiyama Y: Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20: 6898-6906, 2000
14. Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, Saftig P, Uchiyama Y: Participation of autophagy in storage of lysosomes in neurons from mousemodels of neuronal ceroid-lipofuscinoses (Batten disease). AmJ Pathol 167: 1713-1728, 2005
15. Yokota S, Tsuji H, Kato K: Immunocytochemical localization of cathepsin D in lysosomes of cortical collecting tubule cells of the rat kidney. J Histochem Cytochem 33: 191-200, 1985
16. Baricos WH, Shah SV: Increased cathepsin D-like activity in cortex, tubules, and glomeruli isolated from rats with experimental nephrotic syndrome. Biochem J 223: 393-399, 1984
17. Asanuma K, Kim K, Oh J, Giardino L, Chabanis S, Faul C, Reiser J, Mundel P: Synaptopodin regulates the actin-bundling activity of alphaactinin in an isoform-specific manner. J Clin Invest 115: 1188-1198, 2005
18. Grahammer F, Schell C,Huber TB: The podocyte slit diaphragm-from a thin grey line to a complex signalling hub. Nat Rev Nephrol 9: 587-598, 2013
19. Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstädt H, Kerjaschki D, Mizushima N, Shaw AS,Walz G, Huber TB: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084-1096, 2010
20. Cinà DP,Onay T, Paltoo A, Li C, Maezawa Y, De Arteaga J, Jurisicova A, Quaggin SE: Inhibition ofMTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol 23: 412-420, 2012
21. Oshima Y, Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Bokuda K, Narita T, Kurosawa H, Sun-Wada GH,Wada Y, Yamada T, Takemoto M, Saleem MA, Quaggin SE, Itoh H: Prorenin receptor is essential for normal podocyte structure and function. J Am Soc Nephrol 22: 2203-2212, 2011
22. Riediger F,Quack I,Qadri F, Hartleben B, Park JK, Potthoff SA, Sohn D, Sihn G, Rousselle A, Fokuhl V, Maschke U, Purfürst B, Schneider W, Rump LC, Luft FC, Dechend R, Bader M, Huber TB, Nguyen G, Muller DN: Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol 22: 2193-2202, 2011
23. Chen J, Chen MX, Fogo AB, Harris RC, Chen JK: mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J Am Soc Nephrol 24: 198-207, 2013
24. Bechtel W, Helmstädter M, Balica J, Hartleben B, Kiefer B, Hrnjic F, Schell C, Kretz O, Liu S, Geist F, Kerjaschki D,Walz G, Huber TB: Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol 24: 727-743, 2013
25. Gassler N, Elger M, Kränzlin B, Kriz W, Gretz N, Hähnel B, Hosser H, Hartmann I: Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat. Kidney Int 60: 106-116, 2001
26. KimYH, GoyalM, Kurnit D,WharramB,Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001
27. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A: Pathophysiologic implications of reduced podocyte number in a ratmodel of progressive glomerular injury. Am J Pathol 168: 42-54, 2006
28. Asanuma K, Akiba-Takagi M, Kodama F, Asao R, Nagai Y, Lydia A, Fukuda H, Tanaka E, Shibata T, Takahara H, Hidaka T, Asanuma E, Kominami E, Ueno T, Tomino Y: Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy. Am J Nephrol 33: 537-549, 2011
29. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002
30. Shacka JJ:Mouse models of neuronal ceroid lipofuscinoses: Useful preclinical tools to delineate disease pathophysiology and validate therapeutics. Brain Res Bull 88: 43-57, 2012
31. Soda K, Balkin DM, Ferguson SM, Paradise S, Milosevic I, Giovedi S, Volpicelli-Daley L, Tian X, Wu Y, Ma H, Son SH, Zheng R, Moeckel G, Cremona O, Holzman LB, De Camilli P, Ishibe S: Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J Clin Invest 122: 4401-4411, 2012
32. Benes P, Vetvicka V, Fusek M: Cathepsin D-many functions of one aspartic protease. Crit Rev Oncol Hematol 68: 12-28, 2008
33. Zhou W, Scott SA, Shelton SB, Crutcher KA: Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer's disease. Neuroscience 143: 689-701, 2006
34. Haidar B, Kiss RS, Sarov-Blat L, Brunet R, Harder C, McPherson R, Marcel YL: Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux. J Biol Chem 281: 39971-39981, 2006
35. ReidWA, VallerMJ, Kay J: Immunolocalization of cathepsin D in normal and neoplastic human tissues. J Clin Pathol 39: 1323-1330, 1986
36. Siintola E, Partanen S, Strömme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, Tyynelä J: Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129: 1438-1445, 2006
37. Nielsen R, Mollet G, Esquivel EL, Weyer K, Nielsen PK, Antignac C, Christensen EI: Increased lysosomal proteolysis counteracts protein accumulation in the proximal tubule during focal segmental glomerulosclerosis. Kidney Int 84: 902-910, 2013
38. Twomey C, McCarthy JV: Pathways of apoptosis and importance in development. J CellMolMed 9: 345-359, 2005
39. Koike M, Shibata M, Ohsawa Y, Nakanishi H, Koga T, Kametaka S, Waguri S, Momoi T, Kominami E, Peters C, Figura K, Saftig P, Uchiyama Y: Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci 22: 146-161, 2003
40. Nakanishi H, Zhang J, Koike M, Nishioku T, Okamoto Y, Kominami E, von Figura K, Peters C, Yamamoto K, Saftig P, Uchiyama Y: Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci 21: 7526-7533, 2001
41. Shacka JJ, Klocke BJ, Young C, Shibata M, Olney JW, Uchiyama Y, Saftig P, Roth KA: Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis. J Neurosci 27: 2081-2090, 2007
42. Pavenstädt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 83: 253-307, 2003
43. Soda K, Ishibe S: The function of endocytosis in podocytes. Curr Opin Nephrol Hypertens 22: 432-438, 2013
44. Zeng C, Fan Y, Wu J, Shi S, Chen Z, Zhong Y, Zhang C, Zen K, Liu Z: Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol 234: 203-213, 2014
45. Surendran K, Vitiello SP, Pearce DA: Lysosome dysfunction in the pathogenesis of kidney diseases. Pediatr Nephrol 29: 2253-2261, 2014
46. Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, Gartner J: Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 78: 988-998, 2006
47. Hartleben B,Wanner N, Huber TB: Autophagy in glomerular health and disease. Semin Nephrol 34: 42-52, 2014
48. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Podocytespecific expression of cre recombinase in transgenic mice. Genesis 35: 39-42, 2003
49. Tanimoto M, Gohda T, Kaneko S, Hagiwara S, Murakoshi M, Aoki T, Yamada K, Ito T, Matsumoto M, Horikoshi S, Tomino Y: Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. Metabolism 56: 160-167, 2007
50. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621-1629, 2001
51. Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, Pippin JW, Shankland SJ, Uesugi N, Matsusaka T, Nagata M: Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int 83: 1065-1075, 2013